We were delighted to catch up with Professor Vincent Cottin (National Reference Centre for Rare Pulmonary Diseases, Lyon, France) to discuss the challenges associated with investigating rare diseases and the hot topics in idiopathic pulmonary fibrosis.
Questions
- What are the challenges associated with clinical trials investigating rare diseases such as idiopathic pulmonary fibrosis (IPF)? (0:20)
- What are the hot topics and latest research you are looking forward to exploring in IPF during 2021? (2:14)
Disclosures: Vincent Cottin has disclosures with Boehringer Ingelheim and Roche.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ERS 2021 (Virtual).
